Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.475 -0.035 (-0.41%)
Streaming Delayed Price Updated: 12:40 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
60 61 Next >
Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand
Last week, Novavax Inc (NASDAQ: NVAX) received FDA authorization for its updated COVID-19 vaccine, targeting the omicron subvariant XBB.1.5 in  
Via Benzinga
Exposures COVID-19 Product Safety
3 Pharma Stocks to Dump Before the Damage Is Done
There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears. 
Via InvestorPlace
This Could be Novavax's Big Opportunity
Novavax has lagged behind bigger rivals in the vaccine market. 
Via The Motley Fool
Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?
Moderna, Pfizer, and Novavax all are working on combined vaccine candidates. 
Via The Motley Fool
Why Novavax Stock Fell Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading lower Wednesday amid a pullback in the stock, which gained Tuesday after the FDA granted Emergency Use Authorization for the company's updated... 
Via Benzinga
Exposures COVID-19 Product Safety
Up 20% in 1 Month, Is This Stock a Buy?
As Covid cases rise, Novavax is getting more attention again. But will the momentum last? 
Via The Motley Fool
Exposures COVID-19
Novavax's COVID-19 Shot Just In Time, Optimism Surrounds As Demand Picks Up Momentum
Tuesday, the FDA granted an emergency use nod to Novavax Inc's (NASDAQ: NVAX) COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for active immunization to prevent COVID-19 in  
Via Benzinga
Exposures COVID-19 Product Safety
Why Is Tilray (TLRY) Stock Down 4% Today?
Tilray has released its earnings report for its fiscal first quarter of 2024 and mixed results have TLRY stock on a wild ride today! 
Via InvestorPlace
These Apple Insiders Are Selling Shares of AAPL Stock
Apple stock is on the move Wednesday after several insiders at the company, including CEO Tim Cook, sold shares of AAPL. 
Via InvestorPlace
Short Sellers Are Betting Against Novavax (NVAX) Stock
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap. 
Via InvestorPlace
Exposures COVID-19
What's Going On With Moderna Stock Wednesday?
Moderna, Inc (NASDAQ: MRNA) shares are trading higher Wednesday. 
Via Benzinga
Trump's SPAC Partner Digital World, Novavax, Palantir, And Tesla: Why These Stocks Are Trending Today?
U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
The company can now join Pfizer and Moderna in launching an updated booster in the U.S. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety
Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?
Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
Why Pfizer and BioNTech Stocks Zoomed Higher Today
The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle. 
Via The Motley Fool
Exposures COVID-19
NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month
With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done
Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks. 
Via InvestorPlace
Does This Message From Moderna Mean Bad News for Novavax?
So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market. 
Via The Motley Fool
You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10
These stocks look cheap right now -- if the companies can meet their goals. 
Via The Motley Fool
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to... 
Via Benzinga
More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone
New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get... 
Via Benzinga
Exposures COVID-19 Product Safety
Why COVID Vaccine Demand Might Not Be That Strong
COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago. 
Via The Motley Fool
Exposures COVID-19
Novavax Is a Step Behind, Again. Should You Be Worried?
The FDA still is reviewing Novavax's updated vaccine candidate. 
Via The Motley Fool
Exposures Product Safety
DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories
Benzinga 
Via Benzinga
Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today
U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits
The U.S. 
Via Benzinga
Exposures COVID-19 Product Safety
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Novavax says it's working with the FDA to answer final requests as part of the agency's review. 
Via Investor's Business Daily
Exposures COVID-19 Product Safety
7 Biotech Stocks to Sell in September Before They Crash & Burn
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. 
Via InvestorPlace
Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry
On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the... 
Via Benzinga
Exposures COVID-19
Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant
Pirola has about 30 mutations compared with previous omicron versions of the virus. 
Via Investor's Business Daily
Exposures COVID-19
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.